COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …
the greatest medical challenge in decades. We provide a comprehensive review of the …
Hypertension in low-and middle-income countries
AE Schutte, N Srinivasapura Venkateshmurthy… - Circulation …, 2021 - Am Heart Assoc
In recent decades low-and middle-income countries (LMICs) have been witnessing a
significant shift toward raised blood pressure; yet in LMICs, only 1 in 3 are aware of their …
significant shift toward raised blood pressure; yet in LMICs, only 1 in 3 are aware of their …
2020 International Society of Hypertension global hypertension practice guidelines
In the Guidelines, differentiation between optimal and essential standards were not always
possible, and were made in sections where it was most practical and sensible. The …
possible, and were made in sections where it was most practical and sensible. The …
Another decade, another coronavirus
S Perlman - New England Journal of Medicine, 2020 - Mass Medical Soc
For the third time in as many decades, a zoonotic coronavirus has crossed species to infect
human populations. This virus, provisionally called 2019-nCoV, was first identified in …
human populations. This virus, provisionally called 2019-nCoV, was first identified in …
[HTML][HTML] An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo …
AL Lopresti, SJ Smith, H Malvi, R Kodgule - Medicine, 2019 - journals.lww.com
Background: Ashwagandha (Withania somnifera (L.) Dunal) is a herb traditionally used to
reduce stress and enhance wellbeing. The aim of this study was to investigate its anxiolytic …
reduce stress and enhance wellbeing. The aim of this study was to investigate its anxiolytic …
May Measurement Month 2019: the global blood pressure screening campaign of the International Society of Hypertension
Elevated blood pressure remains the single biggest risk factor contributing to the global
burden of disease and mortality. May Measurement Month is an annual global screening …
burden of disease and mortality. May Measurement Month is an annual global screening …
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised
blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult …
blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult …
Hypertension in China: epidemiology and treatment initiatives
JG Wang, W Zhang, Y Li, L Liu - Nature Reviews Cardiology, 2023 - nature.com
The past two to three decades have seen a steady increase in the prevalence of
hypertension in China, largely owing to increased life expectancy and lifestyle changes …
hypertension in China, largely owing to increased life expectancy and lifestyle changes …
[HTML][HTML] World heart federation roadmap for hypertension–A 2021 update
Abstract The World Heart Federation (WHF) Roadmap series covers a large range of
cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions …
cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions …
Hypertension and stroke in Asia: a comprehensive review from HOPE Asia
Stroke is the primary cause of disability and vascular death worldwide, including Asia. Asian
characteristics that differ from the West lead to higher stroke incidence. Stroke epidemiology …
characteristics that differ from the West lead to higher stroke incidence. Stroke epidemiology …